Académique Documents
Professionnel Documents
Culture Documents
of
ASH-2016
&
st
21 Annual CME in Hematology
With International faculty
Executive Committee
Mumbai Hematology Group
President
Dr. M.B. Agarwal
Vice-President
Dr. Farah Jijina
Secretary
Dr Swati Kanakia
Treasurer
Dr. Brijesh Arora
Members
Dr Shubhangi Agale
Dr. S.D. Banavali
Dr. Roshan Colah
Dr. Mukesh Desai
Dr. S. Khodaiji
Dr. Vrinda Kulkarni
Dr. Mamta Manglani
Dr. Navin Khattry
Dr Chandrakala S
Dr. Asha Shah
Dr Shrimati Shetty
Best
of ASH-2016 &
st
21 Annual CME in Hematology
Dear Colleague,
Best of ASH-2016 (which will be held in San Diego in December 2016) and 21st Annual CME in
Hematology will be held under the aegis of Mumbai Hematology Group (MHG) at Hotel ITC
Grand Central, Parel, Mumbai from Thursday to Saturday, 19th to 21st January 2017.
We have already engaged some of the top international faculty from US and Europe for this
event. Emphasis will be on the newer data that will be presented during ASH-2016. We will be
discussing both basics as well as applied aspects (Diagnostic and Therapeutic). Pediatric
subjects will also be covered.
As usual, Team from Nucleus (Mr. Rajesh Sharma, Mr. Yash Agarwal, Mr. Kalpesh Pambhar and
others) has been appointed for managing the event.
The meeting will begin with lunch on day 1 and end with lunch on day 3. You can arrive in the
morning of day 1 and leave by late afternoon on day 3. A large number of rooms have been
booked at same hotel for 2 nights i.e. Thursday and Friday (19th & 20th of January 2017).
Early registration for this event will be the key to make it an economical affair.
Looking forward to your kind participation which will make this academic feast a grand event.
Your sincerely
Dr M B Agarwal, MD
Hematologist & Hemato-Oncologist
President - Mumbai Hematology Group
Mumbai Hematology Group
Dr Henrik Hasle
Professor
Department of Paediatrics,
Aarhus University Hospital Skejby,
Aarhus, Denmark
Dr Ajay Nooka
Assistant Professor
Division of Bone Marrow Transplant
Department of Hematology and Medical Oncology,
Winship Cancer Institute of Emory University,
Atlanta, Georgia, USA
John Mascarenhas, MD
Tisch Cancer Institute, Division of Hematology/Oncology
Icahn School of Medicine at Mount Sinai
New York, USA
Dr Nathan Fowler
Associate Professor,
Department of Lymphoma
The University of Texas MD Anderson
Cancer Center, Houston, TX, USA
Dr A C Newland
Professor
Department of Haematology
Barts Health NHS trust - The Royal London Hospital
London, UK
Dr Neal Young, MD
Senior Investigator
Cell Biology Section, Hematology Branch
National Heart, Lung and Blood Institute
National Institutes of Health, Bethesda, MD, USA
Dr Genoveffa Franchini, MD
Center for Cancer Research
National Cancer Institute (NCI)
National Institutes of Health
Bethesda, MD, USA
Dr Mala K Talekar, MD
Attending Physician, Cancer Immunotherapy Frontier Program
Division of Oncology & Blood and Marrow Transplantation
Department of Pediatrics
The Childrens Hospital of Philadelphia,
Philadelphia, USA
1. Definition and management of high risk myeloma: progress in the last decade
2. Newer Therapeutic options for R/R myeloma: focus on Carfilzomib
3. ASH 2016 updates in myeloma
Dr Ghulam Mufti
Dr Naval Daver
Dr John Mascarenhas 1. Ruxolitinib the past, present and what to expect in the future
2. Case based clinical approach to modern management of ET, PV and PMF, as
well as MPN related AML
3. Updates on MPN from ASH 2016
Dr Hasle Henrik
Dr Mala Talekar
Dr Neal Young
Dr A C Newland
Dr Flora Peyvandi
Dr Sabine Eichinger
Dr Gnoveffa Fanchini
Dr Andy Fowler
l
Dr Adrian
l
His
l
His
l
He helped
l
He is
Chair of the National Institute for Health and Care Excellence (NICE)
Diagnostic Assessment Programme.
l
He is
l
He
l
He is current advisor to NHS England on pathology
2. Dr Henrik Hasle
l
He
l
He
l
He trained in epidemiology, hematology and pediatrics at Odense University
l
He
l
He was
the chairman of the AML group of the Nordic Society for Pediatric
Hematology and Oncology (NOPHO) 2002 to 2010 and continues as
responsible for the data managing of the NOPHO-AML protocols.
l
He is the chairman of the International-BFM-AML group from 2016.
l
He is
the author or coauthor of more than 210 peer reviewed journal articles
mainly dealing with myeloid leukemia in children, genetic predisposition to
cancer, and late effects after cancer therapy.
l
He is
l
As a
l
He is
also the Principal Investigator (PI) of the clinical trials project within the
National Cancer Institute sponsored Myeloproliferative Disorder Research
Consortium (MPD-RC).
l
He has
4. Dr Naval Daver
l
He is
l
He completed his medical school from Grant Medical College and Sir J J group
of hospitals, Mumbai followed by a residency and fellowship in hematologyoncology from Baylor College of Medicine.
l
He has
l
He is PI or Co-PI for over 25 ongoing multicenter or investigator initiated clinical
l
He is
l
She
completed her medical school training from Grant Medical College & Sir
JJ Group of Hospitals, Mumbai, India, with honors in 2001.
l
She
l
Her passion
l
She completed fellowship training in Pediatric Hematology Oncology & Bone
l
She
l
Her
l
She
l
Due
l
In a research
l
She
l
As a Chief
of the Animal Models and Retroviral Vaccines Section, her lab has
been working on HTLV-1 that causes leukemia and a progressive spastic
myelopathy as well as in HIV pathogenesis and vaccine development using
non-human primate models.
l
One of
l
Dr. Franchini
serves the scientific field through editorial duties and has been
an Associate Editor for Blood, Mucosal Immunology, and AIDS Reviews, and
is in frequent demand to review manuscripts for journals including: Journal
of Clinical Investigation, Journal of Experimental Medicine, Journal of
Immunology, Journal of Infectious Diseases, Journal of Virology, Nature
Medicine, Nature Reviews Immunology, Science and Oncogene.
l
She serves
l
Dr. Franchini's
l
She is
l
She received her medical degree from the University of Milan, Italy, is certified
in Haematology and was awarded PhDs from the Maastricht University, The
Netherlands and the University of Milan, Italy for her research in the field of
rare bleeding disorders.
l
Her basic
l
Her research
l
She has authored and co-authored more than 310 scientific publications that
1999, she has been invited as an expert speaker at more than 100
national and international meetings and congresses.
l
She has
l
She participates
l
She is
l
In 2014
she was awarded the Great Hippocrates " that is delivered to Italian
medical researcher of the year.
l
She received
l
She is associate professor of medicine and head of the anticoagulation clinic
l
She serves
l
She is
l
She is a recipient of several international and national academic awards.
9. Dr Neal Young
l
Dr Young
l
He graduated from Harvard College and Johns Hopkins School of Medicine
l
He did medical residency at the Massachusetts General Hospital and training
l
His research
l
His work
l
He has
l
His laboratory has trained dozens of world leaders in hematology.
Recommended Format:
Slide 1
Title + Authors
Slide 2
Introduction
Slide 5 - 7
Results
Slide 3
Objectives
Slide 4
Materials & Methods
Slide 8
Conclusions
Registration fee
Category
Spot Registration
` 9000 /-
` 21000 /-
` 11000 /-
` 21000 /-
All registrations after 31st December 2016 will be considered as spot registrations
Note:
l
Registration
l
Registrations
l
Registration
Accommodation
Accommodation is available at Hotel ITC Grand Central, Parel, Mumbai which is the venue of the meeting.
It will be available only for 2 nights i.e. from 12 noon on Thursday, 19th January 2017 to 12 noon on Saturday,
21st January 2017.
There are 2 options :
a) Single room, single occupancy : ` 13,000/- per night.
b) Double room, double occupancy : ` 15,000/- per night.
Note: For double room - double occupancy, delegates have to forward 2 names themselves.
Refund policy
Refunds towards registration will be done only until 15th December 2016 after deducting 50% towards
administrative charges. Refunds towards accommodation will be done after deducting one day hotel stay
charges. The refunds will be done only on receipt of email indicating the same and one month after the
conference is over.
Online registration
For online registration, you can go to the following link
http://in.eregnow.com/ticketing/register/ASH2016ANNUALCME
Event Manager :
Nucleus
Mr. Rajesh Sharma
Mr. Yash Agarwal
Mr. Kalpesh Pambhar
: + 91 9374073512
: + 91 8790612727
: + 91 9601608846